ID

17146

Description

OPAL - Insulin Glulisine, Diabetes Mellitus; ODM derived from: https://clinicaltrials.gov/show/NCT00272012

Link

https://clinicaltrials.gov/show/NCT00272012

Keywords

Versions (1)
  1. 8/28/16 8/28/16 -
Uploaded on

August 28, 2016

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Diabetes Mellitus Type 2 NCT00272012

English

Eligibility Diabetes Mellitus Type 2 NCT00272012

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
type 2 diabetes mellitus, previously treated with combination therapy of insulin glargine + oad (maximal tolerated dose / approved in combination with insulin according to local spcs (summary of product characteristics), not including use of a-glucosidase inhibitors) for at least 3 months
Description

Diabetes Mellitus, Non-Insulin-Dependent | Combined Modality Therapy | Insulin Glargine Maximum Tolerated Dose | Oral hypoglycemic Maximum Tolerated Dose | Insulin | Glucosidase Inhibitor

Data type

boolean

Alias
UMLS CUI [1]
C0011860
UMLS CUI [2]
C0009429
UMLS CUI [3,1]
C0907402
UMLS CUI [3,2]
C0752079
UMLS CUI [4,1]
C0359086
UMLS CUI [4,2]
C0752079
UMLS CUI [5]
C0021641
UMLS CUI [6]
C1512211
pre-screening hba1c value greater/equal 7% - smaller/equal 9%
Description

Glycosylated hemoglobin A

Data type

boolean

Alias
UMLS CUI [1]
C0019018
fbg (fasting blood glucose) smaller/equal 120 mg/dl (6.6 mmol/l)
Description

Fasting blood glucose measurement

Data type

boolean

Alias
UMLS CUI [1]
C0428568
women are either not of childbearing potential (surgically sterile, or postmenopausal for more than 2 years) or are not pregnant and agree to use a reliable contraceptive measure for the duration of the study. reliable contraceptive measures include the following: systemic contraceptive (oral, implant, injections), diaphragm with intravaginal spermicide, cervical cap, intrauterine device, or condom with spermicide.
Description

Childbearing Potential | Female Sterilization | Postmenopausal state | Pregnancy | Contraceptive methods | CONTRACEPTIVES,SYSTEMIC | Contraceptives, Oral | Contraceptive implant | Contraceptive injection | Vaginal contraceptive diaphragm | Vaginal Spermicides | CERVICAL CAP FOR CONTRACEPTIVE USE | Intrauterine Devices | Female Condoms | Spermicides

Data type

boolean

Alias
UMLS CUI [1]
C3831118
UMLS CUI [2]
C0015787
UMLS CUI [3]
C0232970
UMLS CUI [4]
C0032961
UMLS CUI [5]
C0700589
UMLS CUI [6]
C1874923
UMLS CUI [7]
C0009905
UMLS CUI [8]
C1657106
UMLS CUI [9]
C1656586
UMLS CUI [10]
C0042241
UMLS CUI [11]
C0087145
UMLS CUI [12]
C0493327
UMLS CUI [13]
C0021900
UMLS CUI [14]
C0221829
UMLS CUI [15]
C0037862
ability and willingness to perform blood glucose monitoring using the sponsor-provided blood glucose meter and subject diary at home
Description

Blood glucose monitoring Willing | Blood glucose meter | Subject Diary

Data type

boolean

Alias
UMLS CUI [1,1]
C1820407
UMLS CUI [1,2]
C0600109
UMLS CUI [2]
C0472226
UMLS CUI [3]
C3890583
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
more than two fbg greater 120 mg/dl (6.6 mmol/l) as measured on 5 consecutive days before visit ii
Description

Fasting blood glucose measurement Quantity

Data type

boolean

Alias
UMLS CUI [1,1]
C0428568
UMLS CUI [1,2]
C1265611
active proliferative diabetic retinopathy, as defined by the application of focal or panretinal photocoagulation or vitrectomy, in the 6 months prior to visit 1, or any other unstable (rapidly progressing) retinopathy that may require surgical treatment (including laser photocoagulation)
Description

Proliferative diabetic retinopathy | Focal photocoagulation | Panretinal photocoagulation | Vitrectomy | Retinal Diseases Unstable Rapidly progressive | Operative Surgical Procedures Patient need for | Laser photocoagulation

Data type

boolean

Alias
UMLS CUI [1]
C0154830
UMLS CUI [2]
C1302105
UMLS CUI [3]
C0730064
UMLS CUI [4]
C0042903
UMLS CUI [5,1]
C0035309
UMLS CUI [5,2]
C0443343
UMLS CUI [5,3]
C1838681
UMLS CUI [6,1]
C0543467
UMLS CUI [6,2]
C0686904
UMLS CUI [7]
C0441510
clinically relevant cardiovascular, hepatic, neurologic, endocrine, or other major systemic disease making implementation of the protocol or interpretation of the study results difficult
Description

Cardiovascular Diseases Relevant Clinical | Liver diseases | nervous system disorder | Endocrine System Diseases | Systemic disease Major Interferes with Protocol Compliance | Systemic disease Major Interferes with research results

Data type

boolean

Alias
UMLS CUI [1,1]
C0007222
UMLS CUI [1,2]
C2347946
UMLS CUI [1,3]
C0205210
UMLS CUI [2]
C0023895
UMLS CUI [3]
C0027765
UMLS CUI [4]
C0014130
UMLS CUI [5,1]
C0442893
UMLS CUI [5,2]
C0205164
UMLS CUI [5,3]
C0521102
UMLS CUI [5,4]
C0525058
UMLS CUI [6,1]
C0442893
UMLS CUI [6,2]
C0205164
UMLS CUI [6,3]
C0521102
UMLS CUI [6,4]
C0683954
known impaired hepatic and renal function
Description

Hepatic Insufficiency | Renal Insufficiency

Data type

boolean

Alias
UMLS CUI [1]
C1306571
UMLS CUI [2]
C1565489
history of drug or alcohol abuse
Description

Substance Use Disorders

Data type

boolean

Alias
UMLS CUI [1]
C0038586
history of hypersensitivity to insulin or insulin analogues or any of the excipients in the insulin glulisine formulation
Description

Hypersensitivity Insulin | Hypersensitivity Insulin Analogue | Hypersensitivity Insulin Glulisine Excipient

Data type

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0021641
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C2825028
UMLS CUI [3,1]
C0020517
UMLS CUI [3,2]
C1313386
UMLS CUI [3,3]
C0015237
treatment with any investigational drug in the last month before visit i
Description

Investigational New Drugs

Data type

boolean

Alias
UMLS CUI [1]
C0013230
pregnant or breast-feeding women, or women planning to become pregnant during the study
Description

Pregnancy | Breast Feeding | Pregnancy, Planned

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
UMLS CUI [3]
C0032992
treatment or likelihood of requiring treatment during the study period with drugs not permitted by the clinical study protocol
Description

Illicit Drugs Study Protocol

Data type

boolean

Alias
UMLS CUI [1,1]
C0086190
UMLS CUI [1,2]
C2348563
night shift workers if they are unable to comply with the treatment regimen
Description

Night shift worker Compliance behavior Limited

Data type

boolean

Alias
UMLS CUI [1,1]
C0555008
UMLS CUI [1,2]
C1321605
UMLS CUI [1,3]
C0439801
Back to the top of the page

Similar models

Eligibility Diabetes Mellitus Type 2 NCT00272012

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Diabetes Mellitus, Non-Insulin-Dependent | Combined Modality Therapy | Insulin Glargine Maximum Tolerated Dose | Oral hypoglycemic Maximum Tolerated Dose | Insulin | Glucosidase Inhibitor
Item
type 2 diabetes mellitus, previously treated with combination therapy of insulin glargine + oad (maximal tolerated dose / approved in combination with insulin according to local spcs (summary of product characteristics), not including use of a-glucosidase inhibitors) for at least 3 months
boolean
C0011860 (UMLS CUI [1])
C0009429 (UMLS CUI [2])
C0907402 (UMLS CUI [3,1])
C0752079 (UMLS CUI [3,2])
C0359086 (UMLS CUI [4,1])
C0752079 (UMLS CUI [4,2])
C0021641 (UMLS CUI [5])
C1512211 (UMLS CUI [6])
Glycosylated hemoglobin A
Item
pre-screening hba1c value greater/equal 7% - smaller/equal 9%
boolean
C0019018 (UMLS CUI [1])
Fasting blood glucose measurement
Item
fbg (fasting blood glucose) smaller/equal 120 mg/dl (6.6 mmol/l)
boolean
C0428568 (UMLS CUI [1])
Childbearing Potential | Female Sterilization | Postmenopausal state | Pregnancy | Contraceptive methods | CONTRACEPTIVES,SYSTEMIC | Contraceptives, Oral | Contraceptive implant | Contraceptive injection | Vaginal contraceptive diaphragm | Vaginal Spermicides | CERVICAL CAP FOR CONTRACEPTIVE USE | Intrauterine Devices | Female Condoms | Spermicides
Item
women are either not of childbearing potential (surgically sterile, or postmenopausal for more than 2 years) or are not pregnant and agree to use a reliable contraceptive measure for the duration of the study. reliable contraceptive measures include the following: systemic contraceptive (oral, implant, injections), diaphragm with intravaginal spermicide, cervical cap, intrauterine device, or condom with spermicide.
boolean
C3831118 (UMLS CUI [1])
C0015787 (UMLS CUI [2])
C0232970 (UMLS CUI [3])
C0032961 (UMLS CUI [4])
C0700589 (UMLS CUI [5])
C1874923 (UMLS CUI [6])
C0009905 (UMLS CUI [7])
C1657106 (UMLS CUI [8])
C1656586 (UMLS CUI [9])
C0042241 (UMLS CUI [10])
C0087145 (UMLS CUI [11])
C0493327 (UMLS CUI [12])
C0021900 (UMLS CUI [13])
C0221829 (UMLS CUI [14])
C0037862 (UMLS CUI [15])
Blood glucose monitoring Willing | Blood glucose meter | Subject Diary
Item
ability and willingness to perform blood glucose monitoring using the sponsor-provided blood glucose meter and subject diary at home
boolean
C1820407 (UMLS CUI [1,1])
C0600109 (UMLS CUI [1,2])
C0472226 (UMLS CUI [2])
C3890583 (UMLS CUI [3])
Item Group
C0680251 (UMLS CUI)
Fasting blood glucose measurement Quantity
Item
more than two fbg greater 120 mg/dl (6.6 mmol/l) as measured on 5 consecutive days before visit ii
boolean
C0428568 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
Proliferative diabetic retinopathy | Focal photocoagulation | Panretinal photocoagulation | Vitrectomy | Retinal Diseases Unstable Rapidly progressive | Operative Surgical Procedures Patient need for | Laser photocoagulation
Item
active proliferative diabetic retinopathy, as defined by the application of focal or panretinal photocoagulation or vitrectomy, in the 6 months prior to visit 1, or any other unstable (rapidly progressing) retinopathy that may require surgical treatment (including laser photocoagulation)
boolean
C0154830 (UMLS CUI [1])
C1302105 (UMLS CUI [2])
C0730064 (UMLS CUI [3])
C0042903 (UMLS CUI [4])
C0035309 (UMLS CUI [5,1])
C0443343 (UMLS CUI [5,2])
C1838681 (UMLS CUI [5,3])
C0543467 (UMLS CUI [6,1])
C0686904 (UMLS CUI [6,2])
C0441510 (UMLS CUI [7])
Cardiovascular Diseases Relevant Clinical | Liver diseases | nervous system disorder | Endocrine System Diseases | Systemic disease Major Interferes with Protocol Compliance | Systemic disease Major Interferes with research results
Item
clinically relevant cardiovascular, hepatic, neurologic, endocrine, or other major systemic disease making implementation of the protocol or interpretation of the study results difficult
boolean
C0007222 (UMLS CUI [1,1])
C2347946 (UMLS CUI [1,2])
C0205210 (UMLS CUI [1,3])
C0023895 (UMLS CUI [2])
C0027765 (UMLS CUI [3])
C0014130 (UMLS CUI [4])
C0442893 (UMLS CUI [5,1])
C0205164 (UMLS CUI [5,2])
C0521102 (UMLS CUI [5,3])
C0525058 (UMLS CUI [5,4])
C0442893 (UMLS CUI [6,1])
C0205164 (UMLS CUI [6,2])
C0521102 (UMLS CUI [6,3])
C0683954 (UMLS CUI [6,4])
Hepatic Insufficiency | Renal Insufficiency
Item
known impaired hepatic and renal function
boolean
C1306571 (UMLS CUI [1])
C1565489 (UMLS CUI [2])
Substance Use Disorders
Item
history of drug or alcohol abuse
boolean
C0038586 (UMLS CUI [1])
Hypersensitivity Insulin | Hypersensitivity Insulin Analogue | Hypersensitivity Insulin Glulisine Excipient
Item
history of hypersensitivity to insulin or insulin analogues or any of the excipients in the insulin glulisine formulation
boolean
C0020517 (UMLS CUI [1,1])
C0021641 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C2825028 (UMLS CUI [2,2])
C0020517 (UMLS CUI [3,1])
C1313386 (UMLS CUI [3,2])
C0015237 (UMLS CUI [3,3])
Investigational New Drugs
Item
treatment with any investigational drug in the last month before visit i
boolean
C0013230 (UMLS CUI [1])
Pregnancy | Breast Feeding | Pregnancy, Planned
Item
pregnant or breast-feeding women, or women planning to become pregnant during the study
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0032992 (UMLS CUI [3])
Illicit Drugs Study Protocol
Item
treatment or likelihood of requiring treatment during the study period with drugs not permitted by the clinical study protocol
boolean
C0086190 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
Night shift worker Compliance behavior Limited
Item
night shift workers if they are unable to comply with the treatment regimen
boolean
C0555008 (UMLS CUI [1,1])
C1321605 (UMLS CUI [1,2])
C0439801 (UMLS CUI [1,3])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial